Role of Apoptosis in the Growth Inhibitory Effects of Vitamin D in MCF-7 Cells

  • JoEllen Welsh
  • Maura Simboli-Campbell
  • Carmen J. Narvaez
  • Martin Tenniswood
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 354)


1,25-dihydroxycholecalciferol (1,25(OH)2D3) is the biologically active form of vitamin D, a fat soluble vitamin originally identified as an anti-rachitic factor in the early 1920s. Since that discovery, the molecular pathways by which 1,25(OH)2D3 functions to maintain calcium homeostasis and bone turnover have been intensely investigated. 1,25(OH)2D3 interacts with the vitamin D receptor, which is a member of the steroid/thyroid/retinoic acid superfamily of nuclear receptors, and induces or represses expression of specific genes whose protein products mediate the biological responses attributed to vitamin D. Vitamin D modulated proteins include calcium binding proteins (calbindins D9K, D28K), bone matrix proteins (osteocalcin, osteopontin), digestive enzymes (alkaline phosphatase) and vitamin D metabolizing enzymes (24-hydroxylase). The expression of the vitamin D receptor in tissues not normally involved in calcium homeostasis (such as mammary gland, pancreas and cells of the immune system) suggested additional roles for this hormone, and led to the identification of 1,25(OH)2D3 as a potent regulator of cell differentiation and proliferation. Studies from a number of laboratories have clearly demonstrated that 1,25(OH)2D3 inhibits growth of breast cancer cells in vitro, and causes regression of tumors growing in vivo (1–3), however, the underlying mechanism of the effect of vitamin D has yet to be clarified.


Breast Cancer Cell Human Breast Cancer Cell Breast Cancer Cell Proliferation Breast Cancer Cell Growth Nuclear Matrix Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    K. Colston, S.K. Chander, A.G. Mackay and R.C. Coombes, Effects of synthetic vitamin D analogs on breast cancer cell proliferation in vivo and in vitro. Biochem. Pharm. 44: 693 (1992)CrossRefGoogle Scholar
  2. 2.
    C. Chouvet, U. Berger and R.C. Coombes, 1,25 Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). Journal of Steroid Biochemistry 24: 373 (1986)PubMedCrossRefGoogle Scholar
  3. 3.
    J. Eisman, R.L. Sutherland, M.L. McMenemy, J.C. Fragonas, E.A. Musgrove and G. Pang, Effects of 1,25-dihydroxyvitamin D3 on cell cycle kinetics of T47D human breast cancer cells. J. Cellular Physiology 138: 611 (1989)CrossRefGoogle Scholar
  4. 4.
    G.T. Williams, Programmed Cell Death: Apoptosis and Oncogenesis. Cell 65: 1097 (1991)PubMedCrossRefGoogle Scholar
  5. 5.
    F.A. Oberhammer, K. Hochegger, G. Froschl, R. Tiefenbacher and M. Pavelka, Chromatin condensation during apoptosis is accompanied by degradation of lamin A + B, without enhanced activity of cdc2 kinase, J. Cell Biology 126: 827 (1994)CrossRefGoogle Scholar
  6. 6.
    T.E. Miller, L.A. Beausang, N. Meneghini and G. Lidgard Cell death and nuclear matrix proteins. In: Apoptosis II: The molecular basis of apoptosis in disease. Cold Spring Laboratory Press, NY (1994)Google Scholar
  7. 7.
    C.H. Yang, E.J. Lambie and M. Snyder NUMA:An unusually long coiled-coil related protein in mammalian nucleus. J. Cell Biology 116: 1303 (1991)CrossRefGoogle Scholar
  8. 8.
    F. Oberhammer, J.W. Wilson, C. Dive, I.D. Morris, J.A. Hickman, A.E. Wakeling P.R. Walker and M. Sikorska M, Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of intemucleosomal degradation. EMBO J. 12: 3679 (1993)PubMedGoogle Scholar
  9. 9.
    G.M. Cohen, X.M. Sun, R.T. Snowden, D. Dinsdale and D.N. Skilleter, Key morphological features of apoptosis may occur in the absence of intemucleosomal DNA fragmentation. Biochem. J. 286: 331 (1992)PubMedGoogle Scholar
  10. 10.
    M. Tenniswood, R.S. Guenette, J. Lakins, M. Mooibroek, P. Wong and J.E. Welsh, Active cell death in hormone dependent tissues. Cancer and Metastasis Reviews 11:197 (1992)Google Scholar
  11. 11.
    M. Tenniswood, D. Taillefer, J. Lakins, R.S. Guenette, M. Mooibroek, L. Daehlin and J.E. Welsh, Control of gene expression during apoptosis in hormone-dependent tissues. In: Apoptosis II: The molecular basis of apoptosis in disease. Cold Spring Laboratory Press, NY (1994)Google Scholar
  12. 12.
    R.S. Guenette, H. Corbeil, J. Leger, K. Wong, V. Mezl, M. Mooibroek and M. Tenniswood, Induction of gene expression during involution of the lactating mammary gland of the rat. J. Molecular Endocrinology 12: 47 (1994)CrossRefGoogle Scholar
  13. 13.
    N. Kyprianou, H. English, N. Davidson and J. Isaacs, Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Research 51: 162 (1991)PubMedGoogle Scholar
  14. 14.
    A.M. Warri, R.L. Huovinen, A.M. Laine, P.M. Martikainen and P.L. Harkonen, Apoptosis in toremifeneinduced growth inhibition of human breast cancer cells in vivo and in vitro. Journal of National Cancer Institute 85: 1412 (1993)CrossRefGoogle Scholar
  15. 15.
    S. Bardon, F. Vignon, P. Montcourrier and H. Rochefort, Steroid receptor mediated cytotoxicity of an anti-estrogen and an antiprogestin in breast cancer cells. Cancer Research 47: 1441 (1987)PubMedGoogle Scholar
  16. 16.
    G. Bellomo, M. Perotti, F. Taddei, F. Mirabelli, G. Finardi, P. Nicotera and S. Orrenius, Tumor Necrosis Factor a induces apoptosis in mammary adenocarcinoma cells by an increase in intranuclear free calcium concentration and DNA fragmentation. Cancer Research 52: 1342 (1992)PubMedGoogle Scholar
  17. 17.
    Armstrong DK, Isaacs JT, Ottaviano YL and Davidson NE (1992) Programmed cell death in an estrogen independent human breast cancer cell line, MDA-MB-468. Cancer Research 52: 3418–3424PubMedGoogle Scholar
  18. 18.
    M. Simboli-Campbell and J. Welsh, 1,25-Dihydroxyvitamin D3: Coordinate regulator of active cell death and proliferation in MCF-7 breast cancer cells. Schering Foundation Workshop, vol. 14, Workshop on Apoptosis in hormone dependent cancers, Springer Verlag, Berlin, In press, (1994)Google Scholar
  19. 19.
    J. Welsh, M. Simboli-Campbell and M. Tenniswood, Induction of apoptotic cell death by 1,25(OH)2D3 in MCF-7 breast cancer cells. Proceedings of the Ninth Workshop on Vitamin D, Walter DeGruyter and Co. Berlin, In press (1994)Google Scholar
  20. 20.
    M. Simboli-Campbell, C.J. Narvaez, M. Tenniswood and J. Welsh, 1,25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells. Submitted for publication.Google Scholar
  21. 21.
    M. Simboli-Campbell and J. Welsh, Comparative effects of 1,25(OH)2D3 and EB1089 on Cell cycle kinetics in MCF-7 cells. Proceedings of the Ninth Workshop on Vitamin D, Walter DeGruyter and Co. Berlin, In press (1994)Google Scholar
  22. 22.
    P.R. Walker, J. Kwast-Welfeld, H. Gourdeau, J. Leblanc, W. Neugebauer and M. Sikorska, Relationship between apoptosis and the cell cycle in lymphocytes:roles of protein kinase C, tyrosine phosphorylation and API. Experimental Cell Research 207: 142 (1993)PubMedCrossRefGoogle Scholar
  23. 23.
    Y.S. Cho-Chung YS and P.M. Gullino, Mammary tumor regression V. Role of acid ribonuclease and cathepsin. J. Biol. Chem. 248: 4743 (1973)PubMedGoogle Scholar
  24. 24.
    R.H. Lanzerotti and P.M. Gullino, Activities and quantities of lysosomal enzymes during mammary tumor regression. Cancer Research 32: 2679 (1972)PubMedGoogle Scholar
  25. 25.
    M. Tenniswood, R.S. Guenette, D. Taillefer and M. Mooibroek, The role of growth factors and extracellular proteases in active cell death in the prostate. Schering Foundation Workshop, vol. 14, Workshop on Apoptosis in hormone dependent cancers, Springer Verlag, Berlin, In press, (1994)Google Scholar
  26. 26.
    J. C. Reed, Bcl-2 and the regulation of programmed cell death. J. Cell Biology. 124: 1 (1994)CrossRefGoogle Scholar
  27. 27.
    S.J. Korsmeyer, J.R. Shutter, D.J. Veis, D. E. Merry and Z. N. Oltvai. Bcl-2/bax: a rheostat that regulates an anti-oxidant pathway and cell death. Seminars in Cancer Biology 4: 327 (1993)PubMedGoogle Scholar
  28. 28.
    J. Abe, T. Nakano, Y. Nishii, T. Matsumoto, E. Ogata and K. Ikeda, A novel vitamin D3 analog, 22-oxa-1,25 dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology 129: 832–837Google Scholar
  29. 29.
    M.A. Anzano, J.M. Smith, M.R. Uskokovic, C.W. Peer, L.T. Mullen, J. L. Letterio, M.C. Welsh, M. W. Shrader, D. L. Logsdon, C.L. Driver, C.C. Brown, A.B. Roberts and M.B. Sporn, 1a25-Dihydroxy-16ene-23-yne-26,27-hexafluorocholecalciferol (Ro-24–5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Research 54: 1653 (1994)PubMedGoogle Scholar
  30. 30.
    K.W. Colston, A.G. Mackay, S.Y. James, L. Binderup, S. Chander and R.C. Coombes. EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochemical Pharmacology 44: 2273 (1992)CrossRefGoogle Scholar
  31. 31.
    M. Koga and R.L. Sutherland, Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation. J. Steroid Biochem. Molec. Biol. 39: 445 (1991)CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • JoEllen Welsh
    • 1
  • Maura Simboli-Campbell
    • 1
  • Carmen J. Narvaez
    • 1
  • Martin Tenniswood
    • 1
  1. 1.W. Alton Jones Cell Science CenterLake PlacidUSA

Personalised recommendations